针对作为生物武器的埃博拉威胁的疫苗研发的最新进展。
Recent advances in vaccine development against Ebola threat as bioweapon.
作者信息
Gera Prachi, Gupta Ankit, Verma Priyanka, Singh Joginder, Gupta Jeena
机构信息
Department of Forensic Science, UIPS, Chandigarh University, Chandigarh, Punjab India.
Department of Bioengineering and Biosciences, Lovely Professional University (LPU), Jalandhar - Delhi G.T. Road (NH-1), Phagwara, Punjab 144411 India.
出版信息
Virusdisease. 2017 Sep;28(3):242-246. doi: 10.1007/s13337-017-0398-0. Epub 2017 Sep 11.
Abstract
With the increasing rate of Ebola virus appearance, with multiple natural outbreaks of Ebola hemorrhagic fever, it is worthy of consideration as bioweapon by anti-national groups. Further, with the non-availability of the vaccines against Ebola virus, concerns about the public health emerge. In this regard, this review summarizes the structure, genetics and potential of Ebola virus to be used as a bioweapon. We highlight the recent advances in the treatment strategies and vaccine development against Ebola virus. The understanding of these aspects might lead to effective treatment practices which can be applied during the future outbreaks of Ebola.
摘要
随着埃博拉病毒出现率的上升，埃博拉出血热多次自然爆发，反国家组织有将其作为生物武器的可能。此外，由于缺乏针对埃博拉病毒的疫苗，引发了对公众健康的担忧。在这方面，本综述总结了埃博拉病毒作为生物武器的结构、遗传学及可能性。我们着重介绍了针对埃博拉病毒的治疗策略和疫苗研发的最新进展。对这些方面的了解可能会带来有效的治疗方法，以便在未来埃博拉疫情爆发时应用。
相似文献
1
Recent advances in vaccine development against Ebola threat as bioweapon.针对作为生物武器的埃博拉威胁的疫苗研发的最新进展。
Virusdisease. 2017 Sep;28(3):242-246. doi: 10.1007/s13337-017-0398-0. Epub 2017 Sep 11.
2
Recent advances in the development of vaccines for Ebola virus disease.埃博拉病毒病疫苗研发的最新进展
Virus Res. 2016 Jan 4;211:174-85. doi: 10.1016/j.virusres.2015.10.021. Epub 2015 Oct 24.
3
Development of vaccines for prevention of Ebola virus infection.埃博拉病毒感染预防疫苗的研制。
Microbes Infect. 2015 Feb;17(2):98-108. doi: 10.1016/j.micinf.2014.12.004. Epub 2014 Dec 16.
4
Ebola virus - epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans - an update on its 40 year's journey.埃博拉病毒——流行病学、诊断与防控：对人类的威胁、经验教训及防范计划——40年历程的最新情况
Vet Q. 2017 Dec;37(1):98-135. doi: 10.1080/01652176.2017.1309474.
5
Vaccines against Ebola virus.埃博拉病毒疫苗。
Vaccine. 2018 Aug 28;36(36):5454-5459. doi: 10.1016/j.vaccine.2017.07.054. Epub 2017 Aug 2.
6
[Recent Advances in Vaccines and Drugs Against the Ebola Virus].[抗埃博拉病毒疫苗与药物的最新进展]
Bing Du Xue Bao. 2015 May;31(3):287-92.
7
Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014-2016 Ebola outbreak in West Africa.在2014 - 2016年西非埃博拉疫情高峰期，美国全国样本对埃博拉疫苗的兴趣。
Vaccine. 2017 Jan 23;35(4):508-512. doi: 10.1016/j.vaccine.2016.11.093. Epub 2016 Dec 28.
8
Ebola hemorrhagic Fever and the current state of vaccine development.埃博拉出血热与疫苗研发的现状
Osong Public Health Res Perspect. 2014 Dec;5(6):378-82. doi: 10.1016/j.phrp.2014.09.006. Epub 2014 Nov 1.
9
Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak.加速 2013-2016 年西非埃博拉病毒病疫情期间的疫苗研发。
Curr Top Microbiol Immunol. 2017;411:229-261. doi: 10.1007/82_2017_53.
10
Willingness to pay for an Ebola vaccine during the 2014-2016 ebola outbreak in West Africa: Results from a U.S. National sample.在 2014-2016 年西非埃博拉疫情期间，美国人对埃博拉疫苗的支付意愿：一项美国全国性样本研究结果。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1665-1671. doi: 10.1080/21645515.2018.1423928. Epub 2018 Feb 15.
引用本文的文献
1
Strengthening the United Nations Secretary-General's Mechanism to an alleged use of bioweapons through a quality-assured laboratory response.通过一个经过质量保证的实验室反应，加强联合国秘书长机制以应对所谓的生物武器使用。
Nat Commun. 2021 May 25;12(1):3078. doi: 10.1038/s41467-021-23296-5.
2
Nurses' and Medical Officers' Knowledge, Attitude, and Preparedness Toward Potential Bioterrorism Attacks.护士和医务人员对潜在生物恐怖袭击的知识、态度及准备情况
SAGE Open Nurs. 2019 May 3;5:2377960819844378. doi: 10.1177/2377960819844378. eCollection 2019 Jan-Dec.
3
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.设计和开发针对埃博拉病毒的疫苗、药物和疗法的进展。
Front Immunol. 2018 Aug 10;9:1803. doi: 10.3389/fimmu.2018.01803. eCollection 2018.
本文引用的文献
1
Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.经鼻内接种表达埃博拉病毒糖蛋白GP的减毒1型人副流感病毒在非洲绿猴中具有免疫原性。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02469-16. Print 2017 May 15.
2
Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease.预测埃博拉严重程度：埃博拉病毒病的临床优先排序评分
PLoS Negl Trop Dis. 2017 Feb 2;11(2):e0005265. doi: 10.1371/journal.pntd.0005265. eCollection 2017 Feb.
3
Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium.选择性雌激素受体调节剂通过破坏内溶酶体钙来选择性抑制埃博拉病毒进入。
Sci Rep. 2017 Jan 24;7:41226. doi: 10.1038/srep41226.
4
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).一种重组水疱性口炎病毒载体疫苗预防埃博拉病毒病的有效性和效果：几内亚环状疫苗接种、开放标签、整群随机试验（埃博拉到此为止！）的最终结果
Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23.
5
Ebolavirus evolves in human to minimize the detection by immune cells by accumulating adaptive mutations.埃博拉病毒在人体内进化，通过积累适应性突变来尽量减少被免疫细胞检测到的几率。
Virusdisease. 2016 Jun;27(2):136-44. doi: 10.1007/s13337-016-0305-0. Epub 2016 Feb 22.
6
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.泛埃博拉病毒和泛丝状病毒小鼠单克隆抗体：对埃博拉病毒和苏丹病毒的保护作用
J Virol. 2015 Oct 14;90(1):266-78. doi: 10.1128/JVI.02171-15. Print 2016 Jan 1.
7
Plant-made pharmaceuticals: from 'Edible Vaccines' to Ebola therapeutics.植物源药物：从“可食用疫苗”到埃博拉治疗药物。
Plant Biotechnol J. 2015 Oct;13(8):1013-6. doi: 10.1111/pbi.12460. Epub 2015 Sep 8.
8
A thermostable, chromatographically purified Ebola nano-VLP vaccine.一种经色谱纯化的热稳定埃博拉纳米病毒样颗粒疫苗。
J Transl Med. 2015 Jul 15;13:228. doi: 10.1186/s12967-015-0593-y.
9
The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.多功能埃博拉病毒VP40基质蛋白是一个很有前景的治疗靶点。
Future Virol. 2015 May;10(5):537-546. doi: 10.2217/fvl.15.6.
10
The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases.埃博拉疫情凸显了被动抗体疗法在治疗传染病方面的潜力。
PLoS Pathog. 2015 Apr 23;11(4):e1004717. doi: 10.1371/journal.ppat.1004717. eCollection 2015 Apr.
Zotero 插件